NOF CORPORATION

Activated PEGs for PEGylation

Top > Advantages of NOF > PEGylation Reference

PEGylation Reference

@1) PEG-conjugate

Following figure shows several examples of PEG-aldehyde conjugation with human insulin for various molecular weights of PEG.


Analysis of PEG-ALD-Insulin by SDS-PAGE with Coomassie brilliant blue.
Insulin was reacted with NOF PEG-ALD at 4. The PEGylaed insulin was purified on Q Sepharose Fast Flowcolumn.
lane M molecular weight markers lane 3 PEG(ME-100AL)-insulin eluate
lane 1 insulin lane 4 PEG(ME-200AL)-insulin eluate
lane 2 PEG(ME-050AL)-insulin eluate lane 5 PEG(ME-300AL)-insulin eluate

@ 2) Coupling of PEG derivatives to Proteins: examples of conditions

  1. Coupling of PEG-NHS derivatives to protein amines (PEG-NHS + Protein-NH2) Conditions 1: 50 mM phosphate buffer (pH 7.2), 4, 6 hr*1)
    Conditions 2: Borate-phosphate buffer (pH 8.0), 25, 2 hr*2)
  2. Coupling of PEG-Aldehyde derivatives to the NH2 group of proteins (PEG-Ald + Protein-NH2)
    Conditions : sodium cyanoborohydride (10 equiv.), 4, 20 hr*3)
  3. Coupling of PEG-Maleimide derivatives to the SH group of proteins (PEG-Maleimide + Protein-SH)
    Conditions: 100 mM phosphate buffer (pH 6.5), 4, 4 hr
  4. Coupling of PEG-NH2 derivatives to the COOH group of proteins (PEG-NH2 + Protein-COOH)
    Conditions: 50mM phosphate buffer (pH 7.2), WSC (2 equiv.), 4, 10 hr
  5. Coupling of PEG-p-Nitrophenyloxycarbonyl derivatives to the NH2 group of proteins (PEG-NP + Protein-NH2)
    Conditions: borate-phosphate buffer (pH 8.0-8.3), rt, overnight*2)
References:
*1) Abuchowski, A., et al. (1984) Cancer Biochem. Biophys. 7, 175.
*2) Sartore, L., et al. (1991) Appl. Biochem. Biotechnol. 27, 45
*3) US 5,824,784